OOOksana G. Obertynska

Oksana G. Obertynska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oksana G. Obertynska has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Left Ventricular Remodeling after Percutaneous Coronary Intervention in Acute Myocardial Infarction Complicated by Acute Heart Failure

    by Oksana G. Obertynska, Lesia V. Rasputina, Daria V. Didenko, Andrii V. Solomonchuk

    The aim. To establish the relationship between structural-functional and laboratory parameters in patients with myocardial infarction (MI) and heart failure (HF) undergoing percutaneous coronary intervention (PCI). Materials and methods. We examined 308 MI patients who were divided into 3 groups: 161 patients without signs of acute heart failure (AHF) (group I), 99 with Killip class II-III AHF (group II) and 48 with Killip class IV (cardiogenic shock) (group III). All the patients underwent general clinical examinations: complete blood count, lipid profile, creati-nine, quantitative determination of troponin I, D-dimer, creatine kinase-MB, electrocardiography, coronary angiography with PCI, focused cardiac ultrasound and standard echocardiography over 3-5 days. Results. According to the focused cardiac ultrasound, the majority of MI patients with signs of AHF had preserved left ventricle function, and only 8.2% of patients had left ventricle ejection fraction (LVEF) ˂40%. The most significant structural and functional changes were observed in group II. After PCI, a significant increase in left ventricle contractility was found in all groups, but in the group II, the increase in LVEF was more pronounced. The severity of HF manifestations increased depending on the severity of diastolic dysfunction. Many correlations were established: an inverse relationship between LVEF and the presence of HF, the number ofaffected vessels, proximal left anterior descending artery lesions, low-density lipoprotein cholesterol, and atrium fibrilla-tion; a direct relationship between LVEF and hemoglobin levels and glomerular filtration rate. Conclusions. The vast majority of patients with MI and signs of AHF had preserved left ventricle contractile function. High-grade HF manifestations increase depending on the severity of diastolic dysfunction. Myocardial revascularization in MI pa-tients significantly improves functional and volumetric parameters of myocardial function. Numerous correlations between structural-functional and laboratory parameters in patients with MI and HF who underwent PCI have been established.


  • Open Access

    Modeling using discriminant analysis of the possibility of occurrence and features of the course of various forms of urticaria in ukrainian women depending on the features of anthropo-somatotypological indicators

    by A. M. A. Aladwan, H. V. Chaika, N. V. Belik, D. G. Smolko, O. G. Obertynska

    Annotation. Predicting the risk of occurrence and course of any disease is the most important and central topic of any branch of clinical medicine. This especially applies to chronic and recurrent diseases that lead to deterioration of the bone of life. One of these diseases is urticaria. The use of anthropometric indicators to achieve this goal is an economically, pathogenetically and logically justified choice. The purpose of the study is to build and analyze discriminative models of the possibility of occurrence and features of the course of urticaria in Ukrainian women depending on anthropometric and somatotypological indicators. On the basis of the Military Medical Clinical Center of the Central Region and the Department of Skin and Venereal Diseases with a postgraduate course at the National Pirogov Memorial Medical University, Vinnytsya, a clinical-laboratory and anthropo-somatotypological examination of 40 young Ukrainian women with acute and chronic urticaria of the mild and severe course As a control group, the indicators of body structure and dimensions of 101 practically healthy Ukrainian women of a similar age group were used, which were taken from the data bank of the research center of the National Pirogov Memorial Medical University, Vinnytsya. With the help of the license package “Statistica 6.0”, discriminant models of the possibility of occurrence and characteristics of the course of urticaria in Ukrainian women were built, depending on anthropometric and somatotypological indicators. In Ukrainian women, based on the characteristics of anthropo-somatotypological indicators, reliable discriminative models were built, which allow with a high probability to classify them as “typical” for practically healthy or patients with urticaria, as well as “typical” for mild or severe acute urticaria course (correspondingly correct in 89.4 % of cases, Wilks' Lambda statistic=0.080, p<0.001). When taking into account the structure and body size indicators among women with urticaria, a reliable interpretation of the obtained classification indicators is possible only between a mild and severe course of the disease (correspondingly, the correctness of 52.5 % of cases, Wilks' Lambda statistic=0.465, p<0.001).

  • The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

    by O Obertynska

    Obesity, insulin resistance, renal dysfunction, hyperuricemia are some of the most common causes of resistant hypertension (RH). A close relationship exists between RH and fluid retention. Currently, there is no consensus regarding pathogenetic therapy of RH and there are no studies on the effects of sodium–glucose cotransporter-2 (SGLT2) inhibitors in obese patients with RH and chronic kidney disease (CKD). The aim was to evaluate the effects of dapagliflozin (D) in obese P with RH and CKD stages 3a. 45 obese P (mean body mass index (BMI) 34.2 kg/m2, waist circumference (WC) 104 cm) with true RH and CKD 3a (eGFR 45–59 mL/min/1.73m2) were included in the study under conventional therapy full doses of appropriate combinations (mean 3.7 antihypertensive drugs). The D at daily doses of 10 mg was added to previous treatment. The blood pressure (BP) was measured in the office and by ambulatory BP monitoring. Anthropometry, metabolic profile, including oral glucose tolerance test with insulin, homeostatic model assessment HOMA-R, hematocrit (Hct), uric acid, potassium (K), serum creatinine, calculated GFR were performed at baseline and after 12 weeks treatment. At baseline were excellent correlations between BMI and SBP (r=0.45, P2, uric acid 469±23 nmol/L, K 4,9±0.9 mmol/L. The asymptomatic hyperuricemia was observed in 57%, impaired glucose tolerance in the 37%. After 12 weeks administration of D, the mean 24 h ambulatory BP effectively decreased (−7.6/−4.3 mmHg; P2, P<0.01), WC (−4,8 cm, P<0.01), fasting glucose (−0,8 mmol/L, P<0.01) and uric acid (−42 nmol/L, P<0.01) without changes in insulin secretion and not significant improvement in HOMA-R (2,8±0.7 versus 2.4±0.4). Mean eGFR and K on D remained unchanged, however, the albumin/creatinine ratio decreased significantly (P<0.05). Also, the Hct significantly increased after start of D (P<0.01). By linear regression analysis, the independent associated factor for the change SBP was baseline BMI (P<0.05) and for the change DBP baseline eGFR (P<0.05). Dapagliflozin shows an additional antihypertensive effect when added to the prior combination therapy in obese patients with RH and CKD 3a without risk of hyperkalemia. Dapagliflozin increase hematocrit, possibly due to its diuretic effects and hemoconcentration. So, positive antihypertensive effect D is due to natriuretic effect and decrease fluid retention. Furthermore, there is also a strong indication that the BP effect is also influenced by weight loss and dapagliflozin administration decreased body mass index, waist circumference, fasting glucose and uric acid, with a tendency to decrease the insulin resistance without changes in insulin secretion. Type of funding sources: None.